SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-24-011391
Filing Date
2024-04-08
Accepted
2024-04-08 16:15:51
Documents
28
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A nby20240404_pre14a.htm   iXBRL PRE 14A 897480
6 comp.jpg GRAPHIC 59755
7 diversity.jpg GRAPHIC 65975
8 i01.jpg GRAPHIC 766
9 i02.jpg GRAPHIC 770
10 i04.jpg GRAPHIC 794
11 nby20240404_pre14aimg001.jpg GRAPHIC 5110
12 nby20240404_pre14aimg002.jpg GRAPHIC 5110
13 nby20240404_pre14aimg003.jpg GRAPHIC 5110
14 pry01.jpg GRAPHIC 199279
15 pry02.jpg GRAPHIC 151895
16 sig1.jpg GRAPHIC 6351
17 sig2.jpg GRAPHIC 7623
18 tsr.jpg GRAPHIC 55838
  Complete submission text file 0001437749-24-011391.txt   3052574

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nby-20231231.xsd EX-101.SCH 6045
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20231231_def.xml EX-101.DEF 7207
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20231231_lab.xml EX-101.LAB 13914
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20231231_pre.xml EX-101.PRE 7010
31 EXTRACTED XBRL INSTANCE DOCUMENT nby20240404_pre14a_htm.xml XML 151603
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33678 | Film No.: 24829759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)